These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 7012102
1. The role of radiation therapy in the management of non-metastatic Ewing's sarcoma of bone. Report of the Intergroup Ewing's Sarcoma Study. Perez CA, Tefft M, Nesbit M, Burgert EO, Vietti T, Kissane J, Pritchard DJ, Gehan EA. Int J Radiat Oncol Biol Phys; 1981 Feb; 7(2):141-9. PubMed ID: 7012102 [No Abstract] [Full Text] [Related]
12. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Craft AW, Cotterill SJ, Bullimore JA, Pearson D. Eur J Cancer; 1997 Jun 15; 33(7):1061-9. PubMed ID: 9376188 [Abstract] [Full Text] [Related]
13. Radiotherapy of Ewing's sarcoma. Local control with and without intensive chemotherapy. Chabora BM, Rosen G, Cham W, D'Angio GJ, Tefft M. Radiology; 1976 Sep 15; 120(3):667-71. PubMed ID: 821098 [Abstract] [Full Text] [Related]
14. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies. Bacci G, Picci P, Ferrari S, Mercuri M, Brach del Prever A, Rosito P, Barbieri E, Tienghi A, Forni C. Cancer; 1998 Mar 15; 82(6):1174-83. PubMed ID: 9506366 [Abstract] [Full Text] [Related]
18. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity. Ferrari S, Mercuri M, Rosito P, Mancini A, Barbieri E, Longhi A, Rimondini S, Cesari M, Ruggieri P, Di Liddo M, Bacci G. J Chemother; 1998 Dec 15; 10(6):484-91. PubMed ID: 9876058 [Abstract] [Full Text] [Related]